Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/21/17 → 01/23/18 |
Funding
- Cellceutix Incorporated: $8,687.50
Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Brilacidin Oral Rinse Administered Daily for 7 Weeks in Attenuating Oral Mucositis in Patients with Head and Neck Cancer Receiv
- Keresztes, Roger (PI)
- Kudelka, Andrzej (CoPI)
Project: Research